Industry Research Reports

Home > Reports > Chemical & Material > Systemic Autoimmune Disease Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Systemic Autoimmune Disease Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Industry: Chemical & Material

Published Date: 2026-07-14

Pages: 111 Pages

Report ld: 6924864

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global market for Systemic Autoimmune Disease Diagnostics was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report provides a comprehensive view of the global market for Systemic Autoimmune Disease Diagnostics, covering total sales revenue, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.

The Systemic Autoimmune Disease Diagnostics market size, estimations, and forecasts are presented in terms of sales revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Systemic Autoimmune Disease Diagnostics.

MARKET SEGMENTATION

By Company

Hoffmann-La Roche Ltd
Siemens Healthineers
Abbott Laboratories
Beckman Coulter, Inc.
SQI Diagnostics
Quest Diagnostics
EUROIMMUN AG
AESKU.Diagnostics GmbH & Co. KG
INOVA Diagnostics, Inc.
Crescendo Bioscience, Inc.
bioMerieux SA
Bio-Rad Laboratories, Inc.
Hemagen Diagnostics, Inc.

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Rheumatoid Arthritis
Ankylosing Spondylitis
Systemic Lupus Erythematosus (SLE)
Others

Segment by Application

Hospital
Clinic
Research Institute
Laboratories

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the scope of the report and the global market size (value). It also summarizes market dynamics and recent developments; identifies key drivers and restraints; outlines challenges and risks for players; reviews relevant industry policies.

Chapter 2: Provides a detailed analysis of the Systemic Autoimmune Disease Diagnostics companies' competitive landscape—including revenue shares, recent development plans, and mergers and acquisitions (M&A).

Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.

Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.

Chapter 5: Presents Systemic Autoimmune Disease Diagnostics revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.

Chapter 6: Presents Systemic Autoimmune Disease Diagnostics revenue at the country level. It provides segmented data by Type and by Application for each country/region.

Chapter 7: Profiles key players, detailing the main companies' product revenue, gross margin, product portfolios, recent developments, etc.

Chapter 8: Analysis of Value Chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Systemic Autoimmune Disease Diagnostics Product Introduction

1.2 Global Systemic Autoimmune Disease Diagnostics Market Size Forecast (2021–2032)

1.3 Systemic Autoimmune Disease Diagnostics Market Trends & Drivers

1.3.1 Systemic Autoimmune Disease Diagnostics Industry Trends

1.3.2 Systemic Autoimmune Disease Diagnostics Market Drivers & Opportunities

1.3.3 Systemic Autoimmune Disease Diagnostics Market Challenges

1.3.4 Systemic Autoimmune Disease Diagnostics Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Systemic Autoimmune Disease Diagnostics Players Revenue Ranking (2025)

2.2 Global Systemic Autoimmune Disease Diagnostics Revenue by Company (2021–2026)

2.3 Key Companies’ R&D and Operations Footprint and Headquarters

2.4 Key Companies Systemic Autoimmune Disease Diagnostics Product Offerings

2.5 Key Companies General Availability (GA) Timeline for Systemic Autoimmune Disease Diagnostics

2.6 Systemic Autoimmune Disease Diagnostics Market Competitive Analysis

2.6.1 Systemic Autoimmune Disease Diagnostics Market Concentration Rate (2021–2026)

2.6.2 Top 5 and Top 10 Global Companies by Systemic Autoimmune Disease Diagnostics Revenue in 2025

2.6.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Systemic Autoimmune Disease Diagnostics revenue, 2025

2.7 Mergers & Acquisitions and Expansion

3 Segmentation Systemic Autoimmune Disease Diagnostics Market Classification

3.1 Introduction by Type

3.1.1 Rheumatoid Arthritis

3.1.2 Ankylosing Spondylitis

3.1.3 Systemic Lupus Erythematosus (SLE)

3.1.4 Others

3.1.5 Global Systemic Autoimmune Disease Diagnostics Sales Value by Type

3.1.5.1 Global Systemic Autoimmune Disease Diagnostics Sales Value by Type (2021 vs 2025 vs 2032)

3.1.5.2 Global Systemic Autoimmune Disease Diagnostics Sales Value, by Type (2021–2032)

3.1.5.3 Global Systemic Autoimmune Disease Diagnostics Sales Value, by Type (%), 2021–2032

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospital

4.1.2 Clinic

4.1.3 Research Institute

4.1.4 Laboratories

4.2 Global Systemic Autoimmune Disease Diagnostics Sales Value by Application

4.2.1 Global Systemic Autoimmune Disease Diagnostics Sales Value by Application (2021 vs 2025 vs 2032)

4.2.2 Global Systemic Autoimmune Disease Diagnostics Sales Value by Application (2021–2032)

4.2.3 Global Systemic Autoimmune Disease Diagnostics Sales Value by Application (%), 2021–2032

5 Segmentation by Region

5.1 Global Systemic Autoimmune Disease Diagnostics Sales Value by Region

5.1.1 Global Systemic Autoimmune Disease Diagnostics Sales Value by Region: 2021 vs 2025 vs 2032

5.1.2 Global Systemic Autoimmune Disease Diagnostics Sales Value by Region (2021–2026)

5.1.3 Global Systemic Autoimmune Disease Diagnostics Sales Value by Region (2027–2032)

5.1.4 Global Systemic Autoimmune Disease Diagnostics Sales Value by Region (%), 2021–2032

5.2 North America

5.2.1 North America Systemic Autoimmune Disease Diagnostics Sales Value, 2021–2032

5.2.2 North America Systemic Autoimmune Disease Diagnostics Sales Value by Country (%), 2025 vs 2032

5.3 Europe

5.3.1 Europe Systemic Autoimmune Disease Diagnostics Sales Value, 2021–2032

5.3.2 Europe Systemic Autoimmune Disease Diagnostics Sales Value by Country (%), 2025 vs 2032

5.4 Asia Pacific

5.4.1 Asia Pacific Systemic Autoimmune Disease Diagnostics Sales Value, 2021–2032

5.4.2 Asia Pacific Systemic Autoimmune Disease Diagnostics Sales Value by Subregion (%), 2025 vs 2032

5.5 South America

5.5.1 South America Systemic Autoimmune Disease Diagnostics Sales Value, 2021–2032

5.5.2 South America Systemic Autoimmune Disease Diagnostics Sales Value by Country (%), 2025 vs 2032

5.6 Middle East & Africa

5.6.1 Middle East & Africa Systemic Autoimmune Disease Diagnostics Sales Value, 2021–2032

5.6.2 Middle East & Africa Systemic Autoimmune Disease Diagnostics Sales Value by Country (%), 2025 vs 2032

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Systemic Autoimmune Disease Diagnostics Sales Value Growth Trends, 2021 vs 2025 vs 2032

6.2 Key Countries/Regions Systemic Autoimmune Disease Diagnostics Sales Value, 2021–2032

6.3 United States

6.3.1 United States Systemic Autoimmune Disease Diagnostics Sales Value, 2021–2032

6.3.2 United States Systemic Autoimmune Disease Diagnostics Sales Value by Type (%), 2025 vs 2032

6.3.3 United States Systemic Autoimmune Disease Diagnostics Sales Value by Application, 2025 vs 2032

6.4 Europe

6.4.1 Europe Systemic Autoimmune Disease Diagnostics Sales Value, 2021–2032

6.4.2 Europe Systemic Autoimmune Disease Diagnostics Sales Value by Type (%), 2025 vs 2032

6.4.3 Europe Systemic Autoimmune Disease Diagnostics Sales Value by Application, 2025 vs 2032

6.5 China

6.5.1 China Systemic Autoimmune Disease Diagnostics Sales Value, 2021–2032

6.5.2 China Systemic Autoimmune Disease Diagnostics Sales Value by Type (%), 2025 vs 2032

6.5.3 China Systemic Autoimmune Disease Diagnostics Sales Value by Application, 2025 vs 2032

6.6 Japan

6.6.1 Japan Systemic Autoimmune Disease Diagnostics Sales Value, 2021–2032

6.6.2 Japan Systemic Autoimmune Disease Diagnostics Sales Value by Type (%), 2025 vs 2032

6.6.3 Japan Systemic Autoimmune Disease Diagnostics Sales Value by Application, 2025 vs 2032

6.7 South Korea

6.7.1 South Korea Systemic Autoimmune Disease Diagnostics Sales Value, 2021–2032

6.7.2 South Korea Systemic Autoimmune Disease Diagnostics Sales Value by Type (%), 2025 vs 2032

6.7.3 South Korea Systemic Autoimmune Disease Diagnostics Sales Value by Application, 2025 vs 2032

6.8 Southeast Asia

6.8.1 Southeast Asia Systemic Autoimmune Disease Diagnostics Sales Value, 2021–2032

6.8.2 Southeast Asia Systemic Autoimmune Disease Diagnostics Sales Value by Type (%), 2025 vs 2032

6.8.3 Southeast Asia Systemic Autoimmune Disease Diagnostics Sales Value by Application, 2025 vs 2032

6.9 India

6.9.1 India Systemic Autoimmune Disease Diagnostics Sales Value, 2021–2032

6.9.2 India Systemic Autoimmune Disease Diagnostics Sales Value by Type (%), 2025 vs 2032

6.9.3 India Systemic Autoimmune Disease Diagnostics Sales Value by Application, 2025 vs 2032

7 Company Profiles

7.1 Hoffmann-La Roche Ltd

7.1.1 Hoffmann-La Roche Ltd Profile

7.1.2 Hoffmann-La Roche Ltd Main Business

7.1.3 Hoffmann-La Roche Ltd Systemic Autoimmune Disease Diagnostics Products, Services, and Solutions

7.1.4 Hoffmann-La Roche Ltd Systemic Autoimmune Disease Diagnostics Revenue (US$ Million), 2021–2026

7.1.5 Hoffmann-La Roche Ltd Recent Developments

7.2 Siemens Healthineers

7.2.1 Siemens Healthineers Profile

7.2.2 Siemens Healthineers Main Business

7.2.3 Siemens Healthineers Systemic Autoimmune Disease Diagnostics Products, Services, and Solutions

7.2.4 Siemens Healthineers Systemic Autoimmune Disease Diagnostics Revenue (US$ Million), 2021–2026

7.2.5 Siemens Healthineers Recent Developments

7.3 Abbott Laboratories

7.3.1 Abbott Laboratories Profile

7.3.2 Abbott Laboratories Main Business

7.3.3 Abbott Laboratories Systemic Autoimmune Disease Diagnostics Products, Services, and Solutions

7.3.4 Abbott Laboratories Systemic Autoimmune Disease Diagnostics Revenue (US$ Million), 2021–2026

7.3.5 Abbott Laboratories Recent Developments

7.4 Beckman Coulter, Inc.

7.4.1 Beckman Coulter, Inc. Profile

7.4.2 Beckman Coulter, Inc. Main Business

7.4.3 Beckman Coulter, Inc. Systemic Autoimmune Disease Diagnostics Products, Services, and Solutions

7.4.4 Beckman Coulter, Inc. Systemic Autoimmune Disease Diagnostics Revenue (US$ Million), 2021–2026

7.4.5 Beckman Coulter, Inc. Recent Developments

7.5 SQI Diagnostics

7.5.1 SQI Diagnostics Profile

7.5.2 SQI Diagnostics Main Business

7.5.3 SQI Diagnostics Systemic Autoimmune Disease Diagnostics Products, Services, and Solutions

7.5.4 SQI Diagnostics Systemic Autoimmune Disease Diagnostics Revenue (US$ Million), 2021–2026

7.5.5 SQI Diagnostics Recent Developments

7.6 Quest Diagnostics

7.6.1 Quest Diagnostics Profile

7.6.2 Quest Diagnostics Main Business

7.6.3 Quest Diagnostics Systemic Autoimmune Disease Diagnostics Products, Services, and Solutions

7.6.4 Quest Diagnostics Systemic Autoimmune Disease Diagnostics Revenue (US$ Million), 2021–2026

7.6.5 Quest Diagnostics Recent Developments

7.7 EUROIMMUN AG

7.7.1 EUROIMMUN AG Profile

7.7.2 EUROIMMUN AG Main Business

7.7.3 EUROIMMUN AG Systemic Autoimmune Disease Diagnostics Products, Services, and Solutions

7.7.4 EUROIMMUN AG Systemic Autoimmune Disease Diagnostics Revenue (US$ Million), 2021–2026

7.7.5 EUROIMMUN AG Recent Developments

7.8 AESKU.Diagnostics GmbH & Co. KG

7.8.1 AESKU.Diagnostics GmbH & Co. KG Profile

7.8.2 AESKU.Diagnostics GmbH & Co. KG Main Business

7.8.3 AESKU.Diagnostics GmbH & Co. KG Systemic Autoimmune Disease Diagnostics Products, Services, and Solutions

7.8.4 AESKU.Diagnostics GmbH & Co. KG Systemic Autoimmune Disease Diagnostics Revenue (US$ Million), 2021–2026

7.8.5 AESKU.Diagnostics GmbH & Co. KG Recent Developments

7.9 INOVA Diagnostics, Inc.

7.9.1 INOVA Diagnostics, Inc. Profile

7.9.2 INOVA Diagnostics, Inc. Main Business

7.9.3 INOVA Diagnostics, Inc. Systemic Autoimmune Disease Diagnostics Products, Services, and Solutions

7.9.4 INOVA Diagnostics, Inc. Systemic Autoimmune Disease Diagnostics Revenue (US$ Million), 2021–2026

7.9.5 INOVA Diagnostics, Inc. Recent Developments

7.10 Crescendo Bioscience, Inc.

7.10.1 Crescendo Bioscience, Inc. Profile

7.10.2 Crescendo Bioscience, Inc. Main Business

7.10.3 Crescendo Bioscience, Inc. Systemic Autoimmune Disease Diagnostics Products, Services, and Solutions

7.10.4 Crescendo Bioscience, Inc. Systemic Autoimmune Disease Diagnostics Revenue (US$ Million), 2021–2026

7.10.5 Crescendo Bioscience, Inc. Recent Developments

7.11 bioMerieux SA

7.11.1 bioMerieux SA Profile

7.11.2 bioMerieux SA Main Business

7.11.3 bioMerieux SA Systemic Autoimmune Disease Diagnostics Products, Services, and Solutions

7.11.4 bioMerieux SA Systemic Autoimmune Disease Diagnostics Revenue (US$ Million), 2021–2026

7.11.5 bioMerieux SA Recent Developments

7.12 Bio-Rad Laboratories, Inc.

7.12.1 Bio-Rad Laboratories, Inc. Profile

7.12.2 Bio-Rad Laboratories, Inc. Main Business

7.12.3 Bio-Rad Laboratories, Inc. Systemic Autoimmune Disease Diagnostics Products, Services, and Solutions

7.12.4 Bio-Rad Laboratories, Inc. Systemic Autoimmune Disease Diagnostics Revenue (US$ Million), 2021–2026

7.12.5 Bio-Rad Laboratories, Inc. Recent Developments

7.13 Hemagen Diagnostics, Inc.

7.13.1 Hemagen Diagnostics, Inc. Profile

7.13.2 Hemagen Diagnostics, Inc. Main Business

7.13.3 Hemagen Diagnostics, Inc. Systemic Autoimmune Disease Diagnostics Products, Services, and Solutions

7.13.4 Hemagen Diagnostics, Inc. Systemic Autoimmune Disease Diagnostics Revenue (US$ Million), 2021–2026

7.13.5 Hemagen Diagnostics, Inc. Recent Developments

8 Industry Chain Analysis

8.1 Systemic Autoimmune Disease Diagnostics Value Chain

8.2 Systemic Autoimmune Disease Diagnostics Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Key Suppliers of Raw Materials

8.2.3 Cost Structure

8.3 Midstream Analysis

8.4 Downstream (Customer) Analysis

8.5 Sales Model and Sales Channelss

8.5.1 Systemic Autoimmune Disease Diagnostics Sales Model

8.5.2 Sales Channels

8.5.3 Systemic Autoimmune Disease Diagnostics Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Systemic Autoimmune Disease Diagnostics Market Trends

Table 2. Systemic Autoimmune Disease Diagnostics Market Drivers & Opportunities

Table 3. Systemic Autoimmune Disease Diagnostics Market Challenges

Table 4. Systemic Autoimmune Disease Diagnostics Market Restraints

Table 5. Global Systemic Autoimmune Disease Diagnostics Revenue by Company (US$ Million), 2021–2026

Table 6. Global Systemic Autoimmune Disease Diagnostics Revenue Market Share by Company (2021–2026)

Table 7. Key Companies’ R&D and Operations Footprint and Headquarters

Table 8. Key Companies Systemic Autoimmune Disease Diagnostics Product Type

Table 9. Key Companies General Availability (GA) Timeline for Systemic Autoimmune Disease Diagnostics

Table 10. Global Systemic Autoimmune Disease Diagnostics Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Systemic Autoimmune Disease Diagnostics revenue, 2025

Table 12. Mergers & Acquisitions and Expansion Plans

Table 13. Global Systemic Autoimmune Disease Diagnostics Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)

Table 14. Global Systemic Autoimmune Disease Diagnostics Sales Value by Type (US$ Million), 2021–2026

Table 15. Global Systemic Autoimmune Disease Diagnostics Sales Value by Type (US$ Million), 2027–2032

Table 16. Global Systemic Autoimmune Disease Diagnostics Sales Market Share in Value by Type (2021–2026)

Table 17. Global Systemic Autoimmune Disease Diagnostics Sales Market Share in Value by Type (2027–2032)

Table 18. Global Systemic Autoimmune Disease Diagnostics Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)

Table 19. Global Systemic Autoimmune Disease Diagnostics Sales Value by Application (US$ Million), 2021–2026

Table 20. Global Systemic Autoimmune Disease Diagnostics Sales Value by Application (US$ Million), 2027–2032

Table 21. Global Systemic Autoimmune Disease Diagnostics Sales Market Share in Value by Application (2021–2026)

Table 22. Global Systemic Autoimmune Disease Diagnostics Sales Market Share in Value by Application (2027–2032)

Table 23. Global Systemic Autoimmune Disease Diagnostics Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032

Table 24. Global Systemic Autoimmune Disease Diagnostics Sales Value by Region (US$ Million), 2021–2026

Table 25. Global Systemic Autoimmune Disease Diagnostics Sales Value by Region (US$ Million), 2027–2032

Table 26. Global Systemic Autoimmune Disease Diagnostics Sales Value by Region (%), 2021–2026

Table 27. Global Systemic Autoimmune Disease Diagnostics Sales Value by Region (%), 2027–2032

Table 28. Key Countries/Regions Systemic Autoimmune Disease Diagnostics Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032

Table 29. Key Countries/Regions Systemic Autoimmune Disease Diagnostics Sales Value, (US$ Million), 2021–2026

Table 30. Key Countries/Regions Systemic Autoimmune Disease Diagnostics Sales Value, (US$ Million), 2027–2032

Table 31. Hoffmann-La Roche Ltd Basic Information List

Table 32. Hoffmann-La Roche Ltd Description and Business Overview

Table 33. Hoffmann-La Roche Ltd Systemic Autoimmune Disease Diagnostics Products, Services, and Solutions

Table 34. Revenue (US$ Million) in Systemic Autoimmune Disease Diagnostics Business of Hoffmann-La Roche Ltd (2021–2026)

Table 35. Hoffmann-La Roche Ltd Recent Developments

Table 36. Siemens Healthineers Basic Information List

Table 37. Siemens Healthineers Description and Business Overview

Table 38. Siemens Healthineers Systemic Autoimmune Disease Diagnostics Products, Services, and Solutions

Table 39. Revenue (US$ Million) in Systemic Autoimmune Disease Diagnostics Business of Siemens Healthineers (2021–2026)

Table 40. Siemens Healthineers Recent Developments

Table 41. Abbott Laboratories Basic Information List

Table 42. Abbott Laboratories Description and Business Overview

Table 43. Abbott Laboratories Systemic Autoimmune Disease Diagnostics Products, Services, and Solutions

Table 44. Revenue (US$ Million) in Systemic Autoimmune Disease Diagnostics Business of Abbott Laboratories (2021–2026)

Table 45. Abbott Laboratories Recent Developments

Table 46. Beckman Coulter, Inc. Basic Information List

Table 47. Beckman Coulter, Inc. Description and Business Overview

Table 48. Beckman Coulter, Inc. Systemic Autoimmune Disease Diagnostics Products, Services, and Solutions

Table 49. Revenue (US$ Million) in Systemic Autoimmune Disease Diagnostics Business of Beckman Coulter, Inc. (2021–2026)

Table 50. Beckman Coulter, Inc. Recent Developments

Table 51. SQI Diagnostics Basic Information List

Table 52. SQI Diagnostics Description and Business Overview

Table 53. SQI Diagnostics Systemic Autoimmune Disease Diagnostics Products, Services, and Solutions

Table 54. Revenue (US$ Million) in Systemic Autoimmune Disease Diagnostics Business of SQI Diagnostics (2021–2026)

Table 55. SQI Diagnostics Recent Developments

Table 56. Quest Diagnostics Basic Information List

Table 57. Quest Diagnostics Description and Business Overview

Table 58. Quest Diagnostics Systemic Autoimmune Disease Diagnostics Products, Services, and Solutions

Table 59. Revenue (US$ Million) in Systemic Autoimmune Disease Diagnostics Business of Quest Diagnostics (2021–2026)

Table 60. Quest Diagnostics Recent Developments

Table 61. EUROIMMUN AG Basic Information List

Table 62. EUROIMMUN AG Description and Business Overview

Table 63. EUROIMMUN AG Systemic Autoimmune Disease Diagnostics Products, Services, and Solutions

Table 64. Revenue (US$ Million) in Systemic Autoimmune Disease Diagnostics Business of EUROIMMUN AG (2021–2026)

Table 65. EUROIMMUN AG Recent Developments

Table 66. AESKU.Diagnostics GmbH & Co. KG Basic Information List

Table 67. AESKU.Diagnostics GmbH & Co. KG Description and Business Overview

Table 68. AESKU.Diagnostics GmbH & Co. KG Systemic Autoimmune Disease Diagnostics Products, Services, and Solutions

Table 69. Revenue (US$ Million) in Systemic Autoimmune Disease Diagnostics Business of AESKU.Diagnostics GmbH & Co. KG (2021–2026)

Table 70. AESKU.Diagnostics GmbH & Co. KG Recent Developments

Table 71. INOVA Diagnostics, Inc. Basic Information List

Table 72. INOVA Diagnostics, Inc. Description and Business Overview

Table 73. INOVA Diagnostics, Inc. Systemic Autoimmune Disease Diagnostics Products, Services, and Solutions

Table 74. Revenue (US$ Million) in Systemic Autoimmune Disease Diagnostics Business of INOVA Diagnostics, Inc. (2021–2026)

Table 75. INOVA Diagnostics, Inc. Recent Developments

Table 76. Crescendo Bioscience, Inc. Basic Information List

Table 77. Crescendo Bioscience, Inc. Description and Business Overview

Table 78. Crescendo Bioscience, Inc. Systemic Autoimmune Disease Diagnostics Products, Services, and Solutions

Table 79. Revenue (US$ Million) in Systemic Autoimmune Disease Diagnostics Business of Crescendo Bioscience, Inc. (2021–2026)

Table 80. Crescendo Bioscience, Inc. Recent Developments

Table 81. bioMerieux SA Basic Information List

Table 82. bioMerieux SA Description and Business Overview

Table 83. bioMerieux SA Systemic Autoimmune Disease Diagnostics Products, Services, and Solutions

Table 84. Revenue (US$ Million) in Systemic Autoimmune Disease Diagnostics Business of bioMerieux SA (2021–2026)

Table 85. bioMerieux SA Recent Developments

Table 86. Bio-Rad Laboratories, Inc. Basic Information List

Table 87. Bio-Rad Laboratories, Inc. Description and Business Overview

Table 88. Bio-Rad Laboratories, Inc. Systemic Autoimmune Disease Diagnostics Products, Services, and Solutions

Table 89. Revenue (US$ Million) in Systemic Autoimmune Disease Diagnostics Business of Bio-Rad Laboratories, Inc. (2021–2026)

Table 90. Bio-Rad Laboratories, Inc. Recent Developments

Table 91. Hemagen Diagnostics, Inc. Basic Information List

Table 92. Hemagen Diagnostics, Inc. Description and Business Overview

Table 93. Hemagen Diagnostics, Inc. Systemic Autoimmune Disease Diagnostics Products, Services, and Solutions

Table 94. Revenue (US$ Million) in Systemic Autoimmune Disease Diagnostics Business of Hemagen Diagnostics, Inc. (2021–2026)

Table 95. Hemagen Diagnostics, Inc. Recent Developments

Table 96. Revenue (US$ Million) in Systemic Autoimmune Disease Diagnostics Business of Company 40 (2021–2026)

Table 97. Company 40 Recent Developments

Table 98. Key Raw Materials Lists

Table 99. Key Suppliers of Raw Materials Lists

Table 100. Systemic Autoimmune Disease Diagnostics Downstream Customers

Table 101. Systemic Autoimmune Disease Diagnostics Distributors List

Table 102. Research Programs/Design for This Report

Table 103. Key Data Information from Secondary Sources

Table 104. Key Data Information from Primary Sources

List of Figures

Figure 1. Systemic Autoimmune Disease Diagnostics Product Picture

Figure 2. Global Systemic Autoimmune Disease Diagnostics Sales Value, 2021 vs 2025 vs 2032 (US$ Million)

Figure 3. Global Systemic Autoimmune Disease Diagnostics Sales Value (US$ Million), 2021–2032

Figure 4. Systemic Autoimmune Disease Diagnostics Report Years Considered

Figure 5. Global Systemic Autoimmune Disease Diagnostics Players Revenue Ranking (US$ Million), 2025

Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Systemic Autoimmune Disease Diagnostics Revenue in 2025

Figure 7. Systemic Autoimmune Disease Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 8. Rheumatoid Arthritis Picture

Figure 9. Ankylosing Spondylitis Picture

Figure 10. Systemic Lupus Erythematosus (SLE) Picture

Figure 11. Others Picture

Figure 12. Global Systemic Autoimmune Disease Diagnostics Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032

Figure 13. Global Systemic Autoimmune Disease Diagnostics Sales Value Market Share by Type, 2025 & 2032

Figure 14. Product Picture of Hospital

Figure 15. Product Picture of Clinic

Figure 16. Product Picture of Research Institute

Figure 17. Product Picture of Laboratories

Figure 18. Global Systemic Autoimmune Disease Diagnostics Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032

Figure 19. Global Systemic Autoimmune Disease Diagnostics Sales Value Market Share by Application, 2025 & 2032

Figure 20. North America Systemic Autoimmune Disease Diagnostics Sales Value (US$ Million), 2021–2032

Figure 21. North America Systemic Autoimmune Disease Diagnostics Sales Value by Country (%), 2025 vs 2032

Figure 22. Europe Systemic Autoimmune Disease Diagnostics Sales Value (US$ Million), 2021–2032

Figure 23. Europe Systemic Autoimmune Disease Diagnostics Sales Value by Country (%), 2025 vs 2032

Figure 24. Asia Pacific Systemic Autoimmune Disease Diagnostics Sales Value (US$ Million), 2021–2032

Figure 25. Asia Pacific Systemic Autoimmune Disease Diagnostics Sales Value by Subregion (%), 2025 vs 2032

Figure 26. South America Systemic Autoimmune Disease Diagnostics Sales Value (US$ Million), 2021–2032

Figure 27. South America Systemic Autoimmune Disease Diagnostics Sales Value by Country (%), 2025 vs 2032

Figure 28. Middle East & Africa Systemic Autoimmune Disease Diagnostics Sales Value (US$ Million), 2021–2032

Figure 29. Middle East & Africa Systemic Autoimmune Disease Diagnostics Sales Value by Country (%), 2025 vs 2032

Figure 30. Key Countries/Regions Systemic Autoimmune Disease Diagnostics Sales Value (%), 2021–2032

Figure 31. United States Systemic Autoimmune Disease Diagnostics Sales Value (US$ Million), 2021–2032

Figure 32. United States Systemic Autoimmune Disease Diagnostics Sales Value by Type (%), 2025 vs 2032

Figure 33. United States Systemic Autoimmune Disease Diagnostics Sales Value by Application (%), 2025 vs 2032

Figure 34. Europe Systemic Autoimmune Disease Diagnostics Sales Value (US$ Million), 2021–2032

Figure 35. Europe Systemic Autoimmune Disease Diagnostics Sales Value by Type (%), 2025 vs 2032

Figure 36. Europe Systemic Autoimmune Disease Diagnostics Sales Value by Application (%), 2025 vs 2032

Figure 37. China Systemic Autoimmune Disease Diagnostics Sales Value (US$ Million), 2021–2032

Figure 38. China Systemic Autoimmune Disease Diagnostics Sales Value by Type (%), 2025 vs 2032

Figure 39. China Systemic Autoimmune Disease Diagnostics Sales Value by Application (%), 2025 vs 2032

Figure 40. Japan Systemic Autoimmune Disease Diagnostics Sales Value (US$ Million), 2021–2032

Figure 41. Japan Systemic Autoimmune Disease Diagnostics Sales Value by Type (%), 2025 vs 2032

Figure 42. Japan Systemic Autoimmune Disease Diagnostics Sales Value by Application (%), 2025 vs 2032

Figure 43. South Korea Systemic Autoimmune Disease Diagnostics Sales Value (US$ Million), 2021–2032

Figure 44. South Korea Systemic Autoimmune Disease Diagnostics Sales Value by Type (%), 2025 vs 2032

Figure 45. South Korea Systemic Autoimmune Disease Diagnostics Sales Value by Application (%), 2025 vs 2032

Figure 46. Southeast Asia Systemic Autoimmune Disease Diagnostics Sales Value (US$ Million), 2021–2032

Figure 47. Southeast Asia Systemic Autoimmune Disease Diagnostics Sales Value by Type (%), 2025 vs 2032

Figure 48. Southeast Asia Systemic Autoimmune Disease Diagnostics Sales Value by Application (%), 2025 vs 2032

Figure 49. India Systemic Autoimmune Disease Diagnostics Sales Value (US$ Million), 2021–2032

Figure 50. India Systemic Autoimmune Disease Diagnostics Sales Value by Type (%), 2025 vs 2032

Figure 51. India Systemic Autoimmune Disease Diagnostics Sales Value by Application (%), 2025 vs 2032

Figure 52. Systemic Autoimmune Disease Diagnostics Value Chain

Figure 53. Systemic Autoimmune Disease Diagnostics Cost Structure

Figure 54. Channels of Distribution (Direct Sales, and Distribution)

Figure 55. Bottom-up and Top-down Approaches for This Report

Figure 56. Data Triangulation

Figure 57. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Systemic Autoimmune Disease Diagnostics market? zhanKai

The top companies in the global Systemic Autoimmune Disease Diagnostics market are Hoffmann-La Roche Ltd、Siemens Healthineers、Abbott Laboratories.

Related Reports

Global Systemic Autoimmune Disease Diagnostics Market Research Report 2026
The global Systemic Autoimmune Disease Diagnostics market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-27
Pages: 115
USD 2900.00
(Single User License)
Global Systemic Autoimmune Disease Diagnostics Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Systemic Autoimmune Disease Diagnostics market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-10-26
Pages: 143
USD 4900.00
(Single User License)
Global Systemic Autoimmune Disease Diagnostics Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Systemic Autoimmune Disease Diagnostics market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-24
Pages: 91
USD 4250.00
(Single User License)
Systemic Autoimmune Disease Diagnostics- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Systemic Autoimmune Disease Diagnostics was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-24
Pages: 108
USD 3950.00
(Single User License)
Global Systemic Autoimmune Disease Diagnostics Market Research Report 2025
The global market for Systemic Autoimmune Disease Diagnostics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-24
Pages: 86
USD 2900.00
(Single User License)
Global Systemic Autoimmune Disease Diagnostics Market Insights, Forecast to 2030
Market Analysis and Insights: Global Systemic Autoimmune Disease Diagnostics Market
Published Date: 2024-04-28
Pages: 109
USD 4900.00
(Single User License)
Systemic Autoimmune Disease Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Systemic Autoimmune Disease Diagnostics was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-24
Pages: 110
USD 3950.00
(Single User License)
Global Systemic Autoimmune Disease Diagnostics Market Research Report 2024
The global Systemic Autoimmune Disease Diagnostics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-04
Pages: 89
USD 2900.00
(Single User License)

Global Systemic Autoimmune Disease Diagnostics Market Research Report 2026
The global Systemic Autoimmune Disease Diagnostics market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-27
Pages: 115
USD 2900.00 (Single User License)
Global Systemic Autoimmune Disease Diagnostics Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Systemic Autoimmune Disease Diagnostics market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-10-26
Pages: 143
USD 4900.00 (Single User License)
Global Systemic Autoimmune Disease Diagnostics Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Systemic Autoimmune Disease Diagnostics market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-24
Pages: 91
USD 4250.00 (Single User License)
Systemic Autoimmune Disease Diagnostics- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Systemic Autoimmune Disease Diagnostics was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-24
Pages: 108
USD 3950.00 (Single User License)
Global Systemic Autoimmune Disease Diagnostics Market Research Report 2025
The global market for Systemic Autoimmune Disease Diagnostics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-24
Pages: 86
USD 2900.00 (Single User License)
Global Systemic Autoimmune Disease Diagnostics Market Insights, Forecast to 2030
Market Analysis and Insights: Global Systemic Autoimmune Disease Diagnostics Market
Published: 2024-04-28
Pages: 109
USD 4900.00 (Single User License)
Systemic Autoimmune Disease Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Systemic Autoimmune Disease Diagnostics was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-24
Pages: 110
USD 3950.00 (Single User License)
Global Systemic Autoimmune Disease Diagnostics Market Research Report 2024
The global Systemic Autoimmune Disease Diagnostics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-04
Pages: 89
USD 2900.00 (Single User License)